Patient Care
We deliver high-quality care with innovation and empathy.
We deliver high-quality care with innovation and empathy.
PRACTICE SUPPORT
Products
Thousands of end stage renal disease experts turn to Renal Therapies Group for pharmaceuticals and the most prescribed technologies in the industry.
Every day, we’re working tirelessly to transform the future of healthcare. Because every patient deserves treatment as strong as they are.
Insights
Our Company
More
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
President, Renal Therapies Group
Fresenius Medical Care North America
As President of our Renal Therapies Group, Joe Turk oversees renal products and pharmaceutical operations, including sales, clinical support, product marketing and management, customer and technical services, and regulatory affairs. His decades of strategy and market development experience have been critical in expanding our footprint and technologies.
Previously, Joe served as our president of Home and Critical Care Therapies and, before joining our team, was president of NxStage Medical, Inc., which merged with our company in 2019. Prior to his years at NxStage, Joe served as director of New Business Development at Boston Scientific Corporation and as a senior engagement manager for McKinsey & Company’s Midwest Health Care and Biotechnology Practice in Chicago.
Joe received a bachelor of arts degree in economics from Wabash College and his master of business administration in marketing and finance from Northwestern University's Kellogg School of Management.
© 2006-2023 Fresenius Medical Care. All Rights Reserved.